 BEVERLY, Mass., Sept. 16, 2021 GLOBE NEWSWIRE -- LexaGene Holdings, Inc., TSX-V: LXG; OTCQB: LXXGF the Company, a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is pleased to announce it has entered into a Cooperative Research and Development Agreement CRADA with the U.S. Armys Combat Capabilities Development Command DEVCOM 